Algae Extract
Also known as Algae extract, Seaweed extract, Marine algae extract, Generic algae extract (unspecified species)
“No regulator has issued a verdict on this ingredient.”
ALGAE EXTRACT is an umbrella INCI name for cosmetic preparations derived from unspecified algae species. As a non-specific INCI, it does NOT correspond to a single CIR Quick Reference Table row — verified absent from the September 2022 CIR QRT (only 'Algae Exopolysaccharides', 'Algin', and 'Alginic Acid' appear under the 'Alga-' prefix; no plain 'Algae Extract' row). CIR has issued multiple group assessments covering specific algae cohorts: a 09/2015 marine-algae-derivative report (Algae Exopolysaccharides, Algin, Alginic Acid — all rated S), a 09/2019 brown algae assessment (Ascophyllum, Fucus, Laminaria, Macrocystis, Sargassum, Hizikia, Ecklonia, Alaria — most species rated S; some Ecklonia species I), and a 09/2021 marine red algae assessment (Chondrus crispus S, Palmaria palmata S, Porphyra umbilicalis S, several Porphyra species I). None of these reports cover the umbrella 'Algae Extract' INCI directly — each names specific genera. This packet drops the cir scope honestly per the F3 coverage-scope-integrity rule (parallels the IRON OXIDES umbrella INCI pattern where 'IRON OXIDES' plural is verifier-substring-absent from per-CI Annex IV entries). General reviews of cosmetic algae use (PMID 41012480 Bogdan 2025 Pharmaceutics; PMID 25537136 Wang 2015 Bioresource Technology) document marine macroalgae bioactive compound classes (sulfated polysaccharides, polyphenols, carotenoids, fatty acids, peptides) and topical applications (antioxidant, anti-inflammatory, moisturizing, anti-melanogenic) but do not constitute ingredient-specific regulatory evidence for the umbrella INCI. Formulators using 'ALGAE EXTRACT' on a label have not committed to any specific species and therefore cannot inherit any specific genus assessment — products labeled with this umbrella INCI carry inherent identity ambiguity that warrants species-level disclosure for any meaningful safety claim.
Marine macroalgae (brown, red, green) contain bioactive compound classes including sulfated polysaccharides (fucoidans, carrageenans, ulvans), polyphenols (phlorotannins), carotenoids (fucoxanthin), fatty acids, and peptides — documented in topical-formulation reviews (PMID 41012480 Bogdan 2025; PMID 25537136 Wang 2015).
Demonstrated cosmetic uses include antioxidant, anti-inflammatory, moisturizing, anti-melanogenic, and skin-conditioning effects when sourced from specific characterized algae species.
When the species IS specified at the INCI level (CHONDRUS CRISPUS EXTRACT, FUCUS VESICULOSUS EXTRACT, ASCOPHYLLUM NODOSUM EXTRACT, MACROCYSTIS PYRIFERA EXTRACT, etc.), CIR has issued species-level Safe (S) findings in the 09/2019 brown algae and 09/2021 red algae group assessments — see CHONDRUS CRISPUS EXTRACT packet for the canonical sister example.
Long history of food and cosmetic use across multiple algae genera supports general biocompatibility at typical topical exposures — though this benefit accrues to specific characterized species, not to the umbrella INCI.
Umbrella-vs-species INCI ambiguity: 'ALGAE EXTRACT' is a non-specific INCI name that does not commit to any particular algae genus or species. CIR has assessed many specific algae (brown algae 09/2019; marine red algae 09/2021; algae-derived hydrocolloids 09/2015) — but none of these reports cover the umbrella 'Algae Extract' INCI directly. Verified absent from the September 2022 CIR Quick Reference Table; this packet drops the cir scope honestly rather than cite a non-existent QRT row, paralleling the IRON OXIDES umbrella INCI pattern.
Heavy metal accumulation risk: marine algae bioaccumulate arsenic, mercury, lead, and cadmium from seawater (PMID 41012480 documents typical regulatory caps: lead and arsenic 10 ppm, mercury 1 ppm, cadmium 0.3 ppm under WHO/FDA guidance). The umbrella INCI provides no species-level information to predict bioaccumulation profile — Hizikia fusiformis is documented to accumulate inorganic arsenic at much higher levels than most other macroalgae, for example.
Iodine content varies dramatically across algae species — brown algae (Laminaria, Macrocystis kelps) accumulate iodine at concentrations orders of magnitude above red and green algae. The umbrella INCI gives no signal on this. Topical cosmetic exposure is generally below thyroid-relevant thresholds, but this is a species-dependent risk profile.
Allergen and sensitization risk profile is species-dependent. Reviews note allergenicity testing is part of standard cosmetic assessment for algae-based products, but the umbrella INCI cannot trigger any species-specific allergen flag.
Standardization gap: bioactive content (polysaccharides, polyphenols, carotenoids) varies enormously by species, harvest season, and extraction method. The umbrella INCI 'ALGAE EXTRACT' on a label has no enforceable composition standard.